期刊文献+

SKP2及MRP-1/CD9在声门癌及癌旁组织中的表达及其临床意义

Clinical significance of SKP2 and MRP-1/CD9 expression in glottic carcinoma and adjacent tissues
原文传递
导出
摘要 目的:观察声门癌及癌旁组织中SKP2及MRP-1/CD9蛋白的变化意义及其对声门癌手术安全切除范围的指导意义。方法:用免疫组织化学SP法检测38例声门鳞状细胞癌组织及距癌组织边缘2、5、10mm的组织中SKP2及MRP-1/CD9蛋白的表达,并取10例声带息肉组织作对照。结果:SKP2蛋白产物异常表达按息肉黏膜组织、癌旁组织(2、5、10mm)及癌组织的顺序依次递减,差异有统计学意义(均P<0.05);MRP-1/CD9蛋白产物异常表达按息肉黏膜组织、癌旁组织(2、5、10mm)及癌组织的顺序依次递增,差异有统计学意义(均P<0.05)。结论:SKP2及MRP-1/CD9均可作为判断喉癌生物学特性的参考指标,声门癌手术安全切缘以距肿瘤≥5mm的标准较为适宜。 Objective:To study the expression of SKP2 and MRP-1/CD9 protein in glottic cancer and adjacent tissues,and to analyze its significance for a safe surgical margin.Method:Thirty-eight cases of glottic squamous cell carcinoma were studied for its cancer tissue,tissue 2 mm,5 mm ,and 10 mm away from cancer ,and 10 cases of vocal cord polyp were served as control. SKP2 and MRP-1/CD9 protein were examined by immunoh istochemical method.Result:The positive expression of SKP2 proteins decreased in sequence of polyp mucosa,those adjacent to carcinoma (10 mm,5 mm,2 mm ) and cancer tissue,and there was significant difference between them(P〈0.05 );On the contrary,the positive expression of the MRP-1/CD9 proteins increased in sequence of polypusmucosa,those adjacent to carcinoma (10 mm,5 mm,2 mm) and cancer tissue,and there was significant difference between them (P〈0.05).Conclusion:SKP2 and MRP-1/CD may act as the reference index for judging the biological speciality of LSCC. It is appropriate to regard 5 mm or above 5 mm away from tumors as a safe margin for surgical treatment of glottic carcinoma.
出处 《临床耳鼻咽喉头颈外科杂志》 CAS CSCD 北大核心 2010年第4期158-160,165,共4页 Journal of Clinical Otorhinolaryngology Head And Neck Surgery
关键词 声门肿瘤 SKP2 MRP-1/CD9 免疫组织化学 安全切缘 glottic neoplasms SKP2 MRP-1/CD9 immunohistochemistry safe resection margin
  • 相关文献

参考文献6

二级参考文献21

  • 1孙彦,王琪.2002年AJCC喉癌分期方案[J].国外医学(耳鼻咽喉科学分册),2004,28(4):248-249. 被引量:22
  • 2宋西成,潘新良,栾信庸,张庆泉,许风雷,雷大鹏,张立强,刘大昱.喉癌手术切缘的临床判别[J].山东大学基础医学院学报,2004,18(5):301-305. 被引量:6
  • 3游龙贵,孙炜,孙彦,张克辉,张小安,兰玉清.喉癌手术切缘Bcl-2、Bax及Bak蛋白的表达[J].青岛大学医学院学报,2005,41(1):40-42. 被引量:8
  • 4Greene FL, Page DL, Fleming ID, et al. AJCC cancer staging handbook. 6th ed. New York: Springer-Verlag,2002:73 ~ 80
  • 5Wenig B L, Berry B W Jr. Management of patients with positive surgical margins after vertical hemilaryngectomy. Arch Otolaryngol Head Neck Surg, 1995, 121:172-175.
  • 6Milas L, Stephens LC, Meyn RE.Relation of apoptosis to cancer therapy [J].Inivo,1994,8:665.
  • 7Tsujimoto Y.Involvement of the Bcl-2 gene in human ollicular lymphoma [J] .Science,1985,228:1440.
  • 8Hockenbery DM,Nunez G,Milliman C,et al.Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death [J]. Nature,1990,348:334.
  • 9Oltvai ZN,Milliman CL,Korsmeyer SJ.Bcl-2 heterodimerizes in vivo with a conserved hemolog,Bax,that accelerates rogrammed cell death [J]. Cell,1993,74:609.
  • 10Kiefer MC,Brauer MJ,Powers VC,et al.Modulation of apoptosis by the widely distributed Bcl-2 homologe Bak [J].Nature,1995,374;736.

共引文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部